DMD and Duchenne muscular dystrophy: It was recently reported that treatment of 10 DMD patients with an antisense oligonucleotide (NS-065/NCNP-01) that induces skipping of exon 53 in mutated dystrophin transcripts increased the dystrophin/spectrin ratio [34].